Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab -- a translational project in the neoadjuvant GeparQuinto trial.
Br J Cancer
; 107(6): 956-60, 2012 Sep 04.
Article
in En
| MEDLINE
| ID: mdl-22892393
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Quinazolines
/
Breast Neoplasms
/
Biomarkers, Tumor
/
Receptor, ErbB-2
/
Neoadjuvant Therapy
/
Antibodies, Monoclonal, Humanized
/
Antineoplastic Agents
Type of study:
Clinical_trials
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Br J Cancer
Year:
2012
Type:
Article
Affiliation country:
Germany